CVS Health Blows Past Q1 Estimates and Raises Full-Year Outlook
CNBC reported Wednesday that CVS Health delivered a strong first-quarter performance, surpassing analyst estimates on both profit and revenue while lifting its full-year financial targets. The results pointed to meaningful momentum in a company-wide recovery effort that has been closely watched across the health-care sector.
CVS Health Earnings Top Forecasts Across Every Division
CVS reported adjusted earnings of $2.57 per share for the quarter, well above the $2.20 analysts had anticipated. Revenues reached $100.43 billion, a 6.2% increase year-over-year and comfortably ahead of the $95.09 billion consensus estimate. Net income for the period came in at $2.94 billion, nearly doubling the $1.78 billion recorded in the same quarter a year earlier.
The company now expects full-year adjusted profit between $7.30 and $7.50 per share, up from prior guidance of $7 to $7.20. Full-year revenue guidance also moved higher, with management projecting at least $405 billion, versus the previous floor of $400 billion.
Also Read: Fed Holds Rates Steady as Tariff Uncertainty Clouds Outlook
Insurance Unit Leads a Sector-Wide Turnaround Narrative
The clearest headline from the quarter came from the Aetna insurance segment, which had been a source of investor concern for two consecutive years. The unit generated $35.97 billion in revenue, beating the $33.28 billion expected by analysts and rising roughly 3% from the prior-year period.
Critically, Aetna’s medical benefit ratio, which measures costs paid against premiums collected, fell to 84.6% from 87.3% a year earlier. Analysts had penciled in 86.3%. A lower figure signals better cost management relative to premium income. Part of the improvement reflected the absence of a premium deficiency reserve that had weighed on the year-ago comparison.
Large health insurers have been wrestling with elevated medical utilization as Medicare Advantage patients resumed procedures delayed during the pandemic. Many carriers, including Aetna, responded by trimming benefits, cutting membership and exiting loss-making markets.
Background: A Two-Year Restructuring Takes Shape
CVS has been executing a broad overhaul since elevated medical costs first dragged on results. The plan includes roughly $2 billion in cost reductions, closure of underperforming retail pharmacy locations and a leadership reshuffle aimed at stabilizing margins. The pharmacy and consumer wellness segment contributed $31.99 billion in sales, broadly flat year-over-year but still ahead of the $31.70 billion Wall Street had forecast.
The quarterly results reinforce early signs that the restructuring is gaining traction. Analysts caution that the second quarter will provide a more complete picture of medical cost trends across the insurance industry.
Read Next: Health Insurers Brace for Second-Quarter Medical Cost Test
